D-dimer unreliable for ruling out pulmonary embolism in COVID-19
October 14, 2021
“These results suggest that use of D-dimer levels to exclude PE among patients hospitalized with COVID-19 may be inappropriate and have limited clinical utility.”
Beta-blocker reduces lung inflammation in critical COVID-19
September 7, 2021
Metoprolol administration also resulted in better oxygenation and fewer days on intensive mechanical ventilation and in the ICU, compared with no treatment.
Rising meth-related heart failure admissions a ‘crisis,’ costly for society
July 23, 2021
‘They’re not going to die from it overnight, but it will damage the heart slowly,’ a researcher said. Meth-related HF admissions exploded in the western United States over a recent decade.
Prophylactic anticoagulation tied to lower death rate in COVID
June 18, 2021
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.
Subclinical myocarditis found in some athletes post COVID
June 2, 2021
A study that evaluated college athletes recently infected with COVID-19 with comprehensive cardiac testing, including MRI, found a small percentage had myocarditis despite being asymptomatic.
COVID-19 outcomes similar with ECMO or mechanical ventilation
May 4, 2021
Survivors, regardless of the treatment they received, experienced significant deficits and were suffering problems with physical, psychological, and cognitive functioning for months.
New reports guide return to play in athletes with COVID-19
November 13, 2020
Researchers found a high prevalence of pericardial involvement in college-student athletes who have recovered from COVID-19.
New return-to-play recommendations for athletes with COVID-19
November 4, 2020
The American College of Cardiology’s Sports and Exercise Cardiology Section has updated its May 2020 recommendations on safe return to play among athletes affected by COVID-19.